Research Article
Treatment Outcome and Associated Factors among Tuberculosis Patients in Debre Tabor, Northwestern Ethiopia: A Retrospective Study
Table 4
Factors associated with treatment outcome of TB patients in Debre Tabor, 2008–2013,
.
| Variables | Treatment outcome | COR (95% CI) | value | AOR (95% CI) | value | Successful (%) | Unsuccessful (%) |
| Sex | | | | | | | Male | 144 (83.2) | 29 (16.8) | 1.00 | | 1.00 | | Female | 120 (92.3) | 10 (7.7) | 0.414 (0.194–0.883) | 0.023 | 0.347 (0.132–0.917) | 0.033 | Residence | | | | | | | Urban | 158 (85.0) | 29 (15.0) | 1.00 | | 1.00 | | Rural | 106 (84.1) | 10 (7.9) | 0.514 (0.240–1.099) | 0.086 | 0.342 (0.118–0.986) | 0.047 | Age in groups | | | | | | | ≤24 | 80 (90.9) | 8 (9.1) | 1.00 | | 1.00 | | 25–44 | 118 (90.8) | 12 (9.2) | 1.017 (0.398–2.600) | 0.972 | 1.041 (0.298–3.634) | 0.949 | ≥45 | 66 (77.6) | 19 (22.4) | 2.879 (1.185–6.996) | 0.020 | 3.807 (1.155–12.544) | 0.028 | Type of TB | | | | | | | Smear positive PTB | 68 (84.0) | 13 (16.0) | 1.00 | | 1.00 | | Smear negative PTB | 94 (89.5) | 11 (10.5) | 0.612 (0.259–1.449) | 0.264 | 0.240 (0.034–1.724) | 0.156 | Extrapulmonary TB | 102 (87.2) | 15 (12.8) | 0.796 (0.344–1.718) | 0.522 | 0.355 (0.049–2.603) | 0.308 | HIV status | | | | | | | Negative | 160 (89.4) | 19 (10.6) | 1.00 | | 1.00 | | Positive | 35 (85.4) | 6 (14.6) | 1.444 (0.537–3.877) | 0.466 | 1.155 (0.322–4.146) | 0.825 | Unknown | 69 (83.1) | 14 (16.9) | 1.709 (0.810–3.602) | 0.159 | 1.558 (0.312–7.769 | 0.589 | Patient category | | | | | | | New | 234 (87.6) | 33 (12.4) | 1.00 | | 1.00 | | Relapse | 8 (61.5) | 5 (38.5) | 4.432 (1.368–14.355) | 0.013 | 3.906 (0.470–32.483) | 0.207 | Failure | 1 (50.0) | 1 (50.0) | 7.091 (0.433–116.103) | 0.170 | | | Transferred in | 17 (100.0) | 0 (0.00) | | | | | Unknown | 4 (100.0) | 0 (0.00) | | | | | Baseline smear result | | | | | | | Smear positive | 68 (84.0) | 13 (16.0) | 1.0 | | | | Smear negative | 196 (88.3) | 26 (12.9) | 0.694 (0.338–1.426) | 0.320 | 0.460 (0.071–2.963) | 0.414 | Smear result at 2nd month | | | | | | | Positive | 3 (30.0) | 7 (70.0) | 1.00 | | 1.00 | | Negative | 63 (94.0) | 4 (6.0) | 0.027 (0.005–0.147) | 0.000 | 0.056 (0.005–0.577) | 0.015 | Not done | 198 (87.6) | 28 (12.4) | 0.061 (0.015–0.248) | 0.000 | 0.140 (0.004–5.559) | 0.296 | Year of treatment | | | | | | | May 2008–April 2009 | 55 (83.3) | 11 (16.7) | 2.850 (0.856–9.489) | 0.088 | 2.726 (0.319–23.266) | 0.359 | May 2009–April 2010 | 55 (80.9) | 13 (19.1) | 3.368 (1.035–10.965) | 0.044 | 3.650 (0.806–16.522) | 0.093 | May 2010–April 2011 | 43 (87.8) | 6 (12.2) | 1.988 (0.528–7.485) | 0.310 | 3.624 (0.701–18.727) | 0.124 | May 2011–April 2012 | 54 (91.5) | 5 (8.5) | 1.319 (0.336–5.174) | 0.691 | 1.637 (0.302–8.880) | 0.568 | May 2012–April 2013 | 57 (93.4) | 4 (6.6) | 1.00 | | 1.00 | | Total | 264 (87.1) | 39 (12.9) | | | | |
|
|